Arphra/Issuer/BIAF

BIAF

bioAffinity Technologies, Inc.

HealthcareMedical - Diagnostics & ResearchUSUSD

$1.67

Live · FMPMay 29, 2026

AI Brief

Market cap

$7.57M

52w range

0.69 – 13.80

P / E

—

EPS

—

Volume

87.54K

Revenue · FY

—

AI Issuer Brief

Arphra AI

Loading cached brief…

Insider · 30d

Bought

0 txns

Sold

0 txns

Net flow

+$0

Full history →

Price

DB · prices_daily

1M 6M 1Y 5Y

No price history in prices_daily for BIAF.

Peers

No peer list available for BIAF.

Price change · trailing returns

Live · FMP

1D	5D	1M	3M	6M	YTD	1Y	3Y	5Y	10Y	Max
+1.21%	+6.37%	-32.93%	+57.55%	+11.33%	+41.53%	-78.81%	-96.96%	-99.33%	-99.33%	-99.33%

Aftermarket

Live · FMP

May 29, 11:50 PM

Last trade

$1.71

10 sh

Bid

$1.60

20 sh

Ask

$1.71

200 sh

Spread

$0.110

Fair value

Football field →

Weighted blend

—

— vs spot

Recommendation

n/a

0 of 0 methods

Method spread

0bull0bear

±5% threshold

Total assets

—

Total debt

—

Cash & equiv

—

Operating CF

—

Free cash flow

—

Buybacks

—

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

bioAffinity Technologies Reports First Quarter 2026 Results and Expanding Adoption and Clinical Usage of CyPath® Lung
businesswire.com·May 08, 2026

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin